CD274 and neoplasm: PD-L1 palmitoylation is a post-translational modification (PTM) required for the structural integrity and functionality of cell membrane-bound PD-L1 that can be targeted to efficiently promote PD-L1 degradation and enhance T-cell immune responses against tumours [21, 22, 63, 70–73].